Back to results
US 2006/0223847 A1Published application
Anti-coronavirus drug
AssigneeaRigen, Inc.
InventorsNobutaka Fujii, Naoki Yamamoto
Life of this patent
Estimating the term…
Abstract
The present invention provides an anti-coronavirus agent including as an active ingredient as exemplified by nelfinavir and salts thereof, an anti-SARS agent including the anti-coronavirus agent, and a method of treating SARS using the anti-SARS agent.
Claims7
An anti-coronavirus agent comprising as an active ingredient a compound represented by formula (1):
- Formula (1)
- wherein each R1 represents formula (2) or (3) below:
- Formula (2)
- wherein Y is S, O or NH;
- each R3 is independently a C1-C4 alkyl group, C1-C4 alkoxyl group, C1-C4 alkylamino group, amido group, carboxy group, amino group, hydroxy group, or halogen atom;
- m is 0 or 1, and p is an integer from 0 to 5
- Formula (3)
- wherein Y, R3 and m are as above;
- and r is an integer from 0 to 6;
- R2 is independently a C1-C4 alkyl group, C1-C4 alkoxy group, C1-C4 alkylamino group, amido group, carboxy group, amino group, hydroxy group, or halogen atom;
- and
- n is an integer from 0 to 3;
- or a pharmaceutically acceptable salt thereof.
10 more elements
Dependencies are inferred from the claim text.